Benefits
Liver enzyme levels
In a pooled analysis of 7 small trials (mostly in Iran; fatty liver and other groups), chlorella lowered AST by about 9 U/L (16 U/L in fatty liver) but not ALT or ALP overall. In one open-label fatty liver trial, ALT, AST, triglycerides, HbA1c and insulin resistance fell only in the arm adding 1,200 mg a day to metformin plus vitamin E. A later review rated certainty very low.
Mercury excretion
Human evidence is weak. In mouse studies by authors from a chlorella maker, chlorella raised mercury excretion about 1.9 to 2.2-fold. In one open-label, non-randomized human trial by the same company (58 healthy adults, 9 g a day for 3 months), hair mercury fell in the chlorella group but not in untreated controls, and blood mercury fell more than in controls. No placebo-controlled trial was found.
Cholesterol and glucose markers
A pooled analysis of 19 trials (797 people) found chlorella lowered total cholesterol (about 9 mg/dL), LDL cholesterol (about 8 mg/dL) and fasting glucose (about 4 mg/dL), with no change in triglycerides, HDL or BMI. A later pooled analysis of 12 chlorella trials found no clear effect on blood lipids, and an 8-week trial in type 2 diabetes (1,500 mg a day) changed none of the measures.
Immune function
In an 8-week placebo-controlled trial in 51 healthy volunteers, 5 g a day of chlorella raised natural killer cell activity and some immune messengers more than placebo, and a 15-man crossover study found higher salivary IgA after 4 weeks. A placebo-controlled flu vaccine trial saw no overall antibody boost, only higher levels in people 55 or younger on the higher dose. These are small studies with mixed results.
Protein, vitamins and minerals
Commercial chlorella products are about 59% protein by dry weight and contain folate, iron and vitamins D, K and B12, some of which are scarce in plant foods. Because humans cannot digest the cellulose cell wall, most supplements use mechanically broken cells; an animal study found more than 80% of chlorella protein digestible.
Vitamin B12 for vegans and vegetarians
Some high-B12 chlorella products contain inactive B12-like compounds, so content varies by product. In a small open-label study, 17 vegans and vegetarians with signs of low B12 who added 9 g of chlorella a day for about 60 days saw methylmalonic acid, a marker of B12 shortage, fall by about 34%, while blood B12 trended up. Ask a doctor about B12 testing if you eat a vegan diet.
Mechanism of action
Mercury excretion in animal studies
In mice given methylmercury, chlorella raised mercury in feces and urine, and long-term feeding lowered blood, kidney and brain mercury without changing glutathione. How this works, and whether it happens in people, has not been shown in a placebo-controlled trial.
Immune signaling
In a placebo-controlled trial, chlorella raised natural killer cell activity along with interferon-gamma and interleukin-1 beta. Polysaccharides extracted from chlorella have shown immune activity in laboratory work.
Antioxidant nutrients and inflammation markers
Chlorella contains carotenoids, vitamin E and other antioxidant compounds. In a placebo-controlled trial in people with fatty liver, TNF-alpha changed more with chlorella than with placebo, and hs-CRP fell within the chlorella group.
Fiber-mediated lipid effects
Chlorella's indigestible fraction binds bile acids in vitro and, in cholesterol-fed rats, lowered serum cholesterol and increased fecal neutral steroid excretion. This may help explain the small total and LDL cholesterol drops seen in some pooled human trials; it is not a replacement for lipid-lowering medication.
Whole-food micronutrient delivery
Chlorella supplies protein, folate, iron and vitamins D, K and B12 in a whole-food form.
Clinical trials
Systematic review and pooled analysis of 7 randomized trials (8 treatment arms) of Chlorella vulgaris on liver enzymes in people with fatty liver and other groups (metabolic syndrome, type 2 diabetes, healthy adults) (Yarmohammadi et al. 2021, Clinical Nutrition Research)
7 small clinical trials, mostly in Iran.
Evidence review and pooled analysis of 7 randomized trials (8 treatment arms) in NAFLD patients and other groups. AST fell: WMD -9.15 U/L (95% CI -16.09 to -2.21), more in NAFLD (-16.42 U/L, CI -29.75 to -3.09), with high heterogeneity. ALT and ALP did not change overall; ALT fell only in the placebo-controlled subgroup (-4.65 U/L). Lipids were not pooled. Trials were small and mostly in Iran; the authors call for larger studies.
Randomized open-label trial without placebo: Chlorella vulgaris extract 1,200 mg a day plus metformin 750 mg a day and vitamin E 200 mg a day for 3 months, versus metformin 1,250 mg a day plus vitamin E (Panahi et al. 2012, Hepato-Gastroenterology)
76 adults with NAFLD (33 chlorella, 43 comparison).
Randomized open-label trial in 76 adults with NAFLD. Chlorella vulgaris extract 1,200 mg/day plus metformin 750 mg/day and vitamin E for 3 months, versus metformin 1,250 mg/day plus vitamin E. ALT, AST, triglycerides, uric acid, HbA1c and HOMA-IR fell only in the chlorella arm; total and LDL cholesterol, HDL and fasting glucose changed only in the metformin arm. No placebo and unequal metformin doses, so chlorella's own effect is uncertain.
Mouse study: a single 100 mg dose of Parachlorella beyerinckii CK-5 powder given with oral methylmercury; 5 of 6 authors worked at Chlorella Industry Co. Ltd (Uchikawa et al. 2010, The Journal of Toxicological Sciences)
Female C57BL/6N mice, five per group (not humans).
Mercury in feces and urine over 24 hours was about 1.9 and 2.2 times higher with chlorella, while blood and organ mercury did not differ. A follow-up mouse study by the same group found longer feeding lowered blood, kidney and brain mercury. Animal evidence only.
Open-label, non-randomized trial without placebo: 9 g a day of chlorella tablets for 3 months versus no supplement; 4 of 6 authors worked at Chlorella Industry Co. Ltd (Maruyama et al. 2018, Fundamental Toxicological Sciences)
58 healthy volunteers (36 men, 22 women): 35 chlorella, 23 untreated controls.
Hair mercury fell in the chlorella group (p = 0.041) but not in controls (p = 0.362). Blood mercury fell more than in controls (p = 0.038), though the within-group drop was not significant (p = 0.084). Not confirmed in a placebo-controlled trial.
Randomized, double-blind, placebo-controlled trial: 5 g a day of chlorella tablets or placebo for 8 weeks (Kwak et al. 2012, Nutrition Journal)
51 healthy volunteers (23 chlorella, 28 placebo).
NK cell activity, interferon-gamma and interleukin-1 beta rose with chlorella, and interleukin-12 tended to rise; the increases in these cytokines and in NK cell activity were significantly larger than with placebo. The study was small and short.